742: Postpartum venous thromboembolism prophylaxis: A Cost-Effectiveness Analysis

Cost-effectiveness of venous thromboembolism prophylaxis in surgery.

Cost-effectiveness of venous thromboembolism prophylaxis with a new mobile device after total hip arthroplasty.

Recent comparison (SAFE study) of a mobile, synchronized compression device and low-molecular-weight heparin for prophylaxis of venous thromboembolism showed similar efficacy but significant differences in major bleeding. A model was constructed to evaluate any difference in cost-effectiveness between the 2 therapies incorporating rates and probabilities of major bleeding from the SAFE study wi...

Deep venous thrombosis and venous thromboembolism prophylaxis.

"Venous thromboembolism (VTE) remains a significant risk for all surgical patients, despite validated guidelines. Development of VTE remains a high risk in hospitalized surgical patients, leading to complications in up to 30%. The stratification of patient risk factors and subsequent utilization of a validated prophylaxis and treatment regimen is, therefore, of utmost importance. Familiarity wi...

Venous thromboembolism prophylaxis in a general hospital.

OBJECTIVE To evaluate the use of venous thromboembolism (VTE) prophylaxis in a general hospital. METHODS A cross-sectional cohort study at the Hospital Nossa Senhora da Conceição, located in the city of Porto Alegre, Brazil, involving a random sample of patients admitted between October of 2008 and February of 2009. We included patients over 18 years of age and hospitalized for more than 48 h...

Major bleeding rates after prophylaxis against venous thromboembolism: systematic review, meta-analysis, and cost implications.

OBJECTIVES The frequency and consequences of major bleeding associated with anticoagulant prophylaxis for prevention of venous thromboembolism is examined. METHODS We conducted a systematic review and meta-analysis of controlled trials that reported rates of major bleeding after pharmaceutical thromboprophylaxis in patients undergoing major orthopedic surgery. Thromboprophylactic agents were ...